Table 3.
Analysis of sites of recurrence in relation to CEA status
| Recurrence site | CEA ≤ 5 ng/ml, n (%) | CEA > 5 ng/ml, n (%) | P# |
|---|---|---|---|
| Total sites | 185 | 55 | |
| Local | 0.059 | ||
| Present | 25 (13.51) | 14 (25.45) | |
| Absent | 160 (86.49) | 41 (74.55) | |
| Peritoneal | 0.003 | ||
| Present | 78 (42.16) | 11 (20.00) | |
| Absent | 107 (57.84) | 44 (80.00) | |
| Lymph node | 0.372 | ||
| Present | 28 (15.14) | 5 (9.09) | |
| Absent | 157 (84.86) | 50 (90.91) | |
| Liver | 0.011 | ||
| Present | 29 (15.68) | 18 (32.73) | |
| Absent | 156 (84.32) | 37 (67.27) | |
| Lung | 0.822 | ||
| Present | 24 (12.97) | 8 (14.55) | |
| Absent | 161 (87.03) | 47 (85.45) | |
| Other sites* | 0.414 | ||
| Present | 14 (7.57) | 6 (10.91) | |
| Absent | 171 (92.43) | 49 (89.09) |
*Including bone, brain, pancreas, adrenal gland and kidney. #Fisher's exact test.